Report updated Apr 21, 2026

Overview · Full Intel report in progress

myMerlin™ is an established medical app that is completely free. With a 3.6/5 rating from 432 reviews, it shows polarized user reception.

What is myMerlin™?

myMerlin™ is a companion application for the Abbott Insertable Cardiac Monitor (ICM) that facilitates continuous heart rhythm monitoring. The app enables patients to record symptomatic events and securely transmit data to healthcare providers based on physician-configured schedules.

Current Momentum

v2.1 · 12mo ago

Zombie

Last updated 371d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Automated Data TransmissionStandard

Proactively transmits heart rhythm information to healthcare providers according to a physician-set schedule.

Symptom LoggingStandard

Allows users to manually record symptomatic events for review by their medical team.

Transmission ManagementStandard

Provides a dashboard to view the status of past and upcoming data transmissions.

Remote ConfigurationStandard

Supports remote updates to device monitoring settings by healthcare providers for compatible ICM models.

How much does it cost?

Free

Who Built It?

Abbott

(1.1K)

Providing integrated digital interfaces for medical devices and metabolic health tracking to improve patient outcomes and clinical data access.

Portfolio

13

Apps

Free 12
Medical58%
Business25%
Lifestyle8%

Who is Abbott?

Abbott occupies a specialized position where mobile software serves as a critical, regulated interface for proprietary medical hardware, such as cardiac monitors and neurostimulators. Their moat is built on deep clinical integration and regulatory clearances that are difficult for pure-play software competitors to replicate. The recent launch of Lingo marks a strategic expansion into the consumer biowearable market, testing whether their clinical credibility can capture the broader metabolic health category.

Who is Abbott for?

  • Patients with implanted cardiac or neuromodulation devices
  • Medical professionals performing structural heart interventions
  • Health-conscious consumers
Active

Portfolio momentum

The publisher released 7 updates in the last 6 months, with a major release occurring just 2 days ago, indicating high current development focus on their active titles.

Last release · 2d agoActive apps · 4Abandoned · 5

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for myMerlin™?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for myMerlin™

Key Takeaways

The app serves as a secure bridge between the patient's implantable cardiac monitor and their healthcare provider for remote rhythm management.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by myMerlin™, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “myMerlin™ Intelligence Report.” Updated Apr 21, 2026. https://marlvel.ai/intel-report/medical/mymerlin

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0